中国高血压防治指南(2024年修订版)

[101] Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (26): : 2401 - 2410

[102] Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions [J]. BLOOD PRESSURE, 2022, 31 (01) : 164 - 168

[103] Unattended versus Attended Blood Pressure Measurement: Relationship with Retinal Microcirculation [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)

[104] Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial [J]. LANCET, 2022, 400 (10367): : 1927 - 1937

[105] Empagliflozin in Patients with Chronic Kidney Disease..[J].Herrington William G;Staplin Natalie;Wanner Christoph;Green Jennifer B;Hauske Sibylle J;Emberson Jonathan R;Preiss David;Judge Parminder;Mayne Kaitlin J;Ng Sarah Y A;Sammons Emily;Zhu Doreen;Hill Michael;Stevens Will;Wallendszus Karl;Brenner Susanne;Cheung Alfred K;Liu ZhiHong;Li Jing;Hooi Lai Seong;Liu Wen;Kadowaki Takashi;Nangaku Masaomi;Levin Adeera;Cherney David;Maggioni Aldo P;Pontremoli Roberto;Deo Rajat;Goto Shinya;Rossello Xavier

[106] The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.[J].Mehran Roxana;Steg Philippe Gabriel;Pfeffer Marc A.;Jering Karola;Claggett Brian;Lewis Eldrin F.;Granger Christopher;Køber Lars;Maggioni Aldo;Mann Douglas L.;McMurray John J.V.;Rouleau Jean Lucien;Solomon Scott D.;Ducrocq Gregory;Berwanger Otavio;De Pasquale Carmine G.;Landmesser Ulf;Petrie Mark;Leng David Sim Kheng;van der Meer

[107] Adverse Childhood Experiences; Depression; Patient Activation and Medication Adherence Among Patients with Uncontrolled Hypertension..[J].Alvarez Carmen;Perrin Nancy;Carson Kathryn A;Marsteller Jill A;Cooper Lisa A.American journal of hypertension.2022, 4

[108] Elevated body mass index increases the risk of cardiovascular events in hypertensive patients accompanied with obstructive sleep apnea: A cohort study [J]. OBESITY RESEARCH & CLINICAL PRACTICE, 2022, 16 (06) : 491 - 499

[109] Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial [J]. LANCET, 2022, 400 (10361): : 1417 - 1425

[110] Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension..[J].Schutte Aletta E;Jafar Tazeen H;Poulter Neil R;Damasceno Albertino;Khan Nadia A;Nilsson Peter M;Alsaid Jafar;Neupane Dinesh;Kario Kazuomi;Beheiry Hind;Brouwers Sofie;Burger Dylan;Charchar Fadi J;Cho Myeong Chan;Guzik Tomasz J;Haji AlSaedi Ghazi F;Ishaq Muhammad;Itoh Hiroshi;Jones Erika S W;Khan Taskeen;Kokubo Yoshihiro;Kotruchin Praew;Muxfeldt Elizabeth;Odili Augustine;Patil Ma

[101] Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (26): : 2401 - 2410

[102] Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions [J]. BLOOD PRESSURE, 2022, 31 (01) : 164 - 168

[103] Unattended versus Attended Blood Pressure Measurement: Relationship with Retinal Microcirculation [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)

[104] Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial [J]. LANCET, 2022, 400 (10367): : 1927 - 1937

[105] Empagliflozin in Patients with Chronic Kidney Disease..[J].Herrington William G;Staplin Natalie;Wanner Christoph;Green Jennifer B;Hauske Sibylle J;Emberson Jonathan R;Preiss David;Judge Parminder;Mayne Kaitlin J;Ng Sarah Y A;Sammons Emily;Zhu Doreen;Hill Michael;Stevens Will;Wallendszus Karl;Brenner Susanne;Cheung Alfred K;Liu ZhiHong;Li Jing;Hooi Lai Seong;Liu Wen;Kadowaki Takashi;Nangaku Masaomi;Levin Adeera;Cherney David;Maggioni Aldo P;Pontremoli Roberto;Deo Rajat;Goto Shinya;Rossello Xavier

[106] The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.[J].Mehran Roxana;Steg Philippe Gabriel;Pfeffer Marc A.;Jering Karola;Claggett Brian;Lewis Eldrin F.;Granger Christopher;Køber Lars;Maggioni Aldo;Mann Douglas L.;McMurray John J.V.;Rouleau Jean Lucien;Solomon Scott D.;Ducrocq Gregory;Berwanger Otavio;De Pasquale Carmine G.;Landmesser Ulf;Petrie Mark;Leng David Sim Kheng;van der Meer

[107] Adverse Childhood Experiences; Depression; Patient Activation and Medication Adherence Among Patients with Uncontrolled Hypertension..[J].Alvarez Carmen;Perrin Nancy;Carson Kathryn A;Marsteller Jill A;Cooper Lisa A.American journal of hypertension.2022, 4

[108] Elevated body mass index increases the risk of cardiovascular events in hypertensive patients accompanied with obstructive sleep apnea: A cohort study [J]. OBESITY RESEARCH & CLINICAL PRACTICE, 2022, 16 (06) : 491 - 499

[109] Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial [J]. LANCET, 2022, 400 (10361): : 1417 - 1425

[110] Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension..[J].Schutte Aletta E;Jafar Tazeen H;Poulter Neil R;Damasceno Albertino;Khan Nadia A;Nilsson Peter M;Alsaid Jafar;Neupane Dinesh;Kario Kazuomi;Beheiry Hind;Brouwers Sofie;Burger Dylan;Charchar Fadi J;Cho Myeong Chan;Guzik Tomasz J;Haji AlSaedi Ghazi F;Ishaq Muhammad;Itoh Hiroshi;Jones Erika S W;Khan Taskeen;Kokubo Yoshihiro;Kotruchin Praew;Muxfeldt Elizabeth;Odili Augustine;Patil Ma